21 results
8-K
EX-99.2
AUPH
Aurinia Pharmaceuticals Inc
5 Apr 23
Aurinia Pharmaceuticals Announces Promising Topline Data from Renal Biopsy Sub-study of the AURORA Trial
8:16am
with hyperglycemia, diabetes and islet cells death. In studies of lupus nephritis, LUPKYNIS has not had such associations5 1. van Gelder T et al. Expert Rev Clin
8-K
EX-99.1
kthvidyyrtuz
17 Aug 21
Riptide Aurinia Collaboration & License Agreement
4:07pm
DEF 14A
uhtr 6gr09
10 May 21
Definitive proxy
4:06pm
PRE 14A
zl5n0zn0
27 Apr 21
Preliminary proxy
4:32pm
10-K
tcakj t02
24 Feb 21
Annual report
4:09pm
10-K
EX-10.6
kw3cisa1hj 58q8
24 Feb 21
Annual report
4:09pm
6-K
EX-99.2
5nxj jvynsgz
30 Dec 20
Material Change Report
5:30pm
40-F
x1apusr2zuyzw3
5 Mar 20
Annual report (Canada)
4:06pm
40-F
EX-99.1
94wkq
5 Mar 20
Annual report (Canada)
4:06pm
40-F
EX-99.1
8c8 lzglq
19 Mar 19
Annual report (Canada)
4:16pm
40-F
icw7720dnvrwf5om
19 Mar 19
Annual report (Canada)
4:16pm
6-K
EX-99.1
bcuhl2cq6xykmwsbn
21 Oct 14
Aurinia Pharmaceuticals to Host Lupus Opinion Leader Meeting and Webcast on October 23 in New York City
12:00am
40FR12B/A
EX-99.16
d7xqbnfpx0jox
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am